31
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Melphalan, Single-Fraction Total-Body Irradiation and Allogeneic Bone Marrow Transplantation for Acute Leukemia: Review of Transplant-Related Mortality

, , , , &
Pages 565-572 | Accepted 20 Jul 1996, Published online: 01 Jul 2009

References

  • Thomas E., Storb R., Clift R. A., et al. Bone‐marrow transplantation. N. Engl. J. Med. 1975; 292: 832–843, and 895–902
  • Powles R. L., Clink H. M., Spence D., et al. Cyclosporin A to prevent graft‐versus‐host disease in man after allogeneic bone‐marrow transplantation. Lancet 1980; 1: 327–329
  • Powles R. L., Morgenstern G., Clink H. M., et al. The place of bone‐marrow transplantation in acute myeloge‐nous leukaemia. Lancet 1980; 1: 1047–1050
  • Lin H. S., Drzymala R. E. Total body and hemi‐body irradiation. Principles and Practice of Radiation Oncology2nd ed., A. Perez, L. W. Brady, London, Lippincott 1992; 256–263, 1992
  • Clift R. A., Buckner C. D., Appelbaum F. R., et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 1990; 76: 1867–1871
  • Clift R. A., Buckner C. D., Appelbaum F. R., et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood 1991; 77: 1660–1665
  • Petersen F. B., Deeg H. J., Buckner C. D., et al. Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide—a phase I trial. Int. J. Radial. Oncol. Biol. Phy.t. 1992; 23: 1027–1032
  • Bearman S. I., Appelbaum F. R., Buckner C. D., et al. Regimen‐related toxicity in patients undergoing bone marrow transplantation. J. Clin. Oncol. 1988; 6: 1562–1568
  • Deeg H. J. Delayed complications and long‐term effects after bone marrow transplantation. Hematol. Oncol. Clin. North Am. 1990; 4: 641–657
  • Helenglass G., Powles R. L., McElwain T. J., et al. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission. Bone Marrow Transplant. 1988; 3: 21–29
  • Ball G. A. Total body irradiation: a specialised unit. Radiography 1988; 54: 104–108
  • Fife K., Milan S., Westbrook K., Powles R., Tait D. Risk factors for requiring cataract surgery following total body irradiation. Radiother. Oncol. 1994; 33: 93–98
  • Powles R. L., Morgenstern G. R., Kay H. E., et al. Mismatched family donors for bone‐marrow transplantation as treatment for acute leukaemia. Lancet 1983; 1: 612–615
  • Mehta J., Powles R., Horton C., Milan S., Singhal S., Treleaven J. The relationship between donor‐recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA‐identical siblings. Bone Marrow Transplant. 1995; 15: 853–858
  • Singhal S., Mehta J., Powles R., et al. Three weeks of ganciclovir for cytomegaloviraemia after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995; 15: 777–781
  • Powles R., Milan S., Horton C., Singhal S., Treleaven J., Mehta J. A prospective haemato‐oncology patient database: Structure and description. Bone Marrow Transplant. 1996; 17(Suppl 1)S140
  • Powles R., Milan S., Horton C., Singhal S., Treleaven J., Mehta J. A prospective haemato‐oncology patient database for use in routine care and clinical research. Bone Marrow Transplant. 1996; 17(Suppl 1)S55
  • Mehta J., Powles R., Treleaven J., et al. Long‐term follow‐up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide‐total body irradiation and cyclosporine. Bone Marrow Transplant., Accepted for publication
  • Mehta J., Powles R., Treleaven J., et al. Melphalan versus cyclophosphamide with total body irradiation as conditioning for allogeneic bone marrow transplantation in first remission acute myeloid leukemia. Blood 1994; 84(Suppl 1)714a
  • Barrett A., Depledge M. H., Biol M., Powles R. L. Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation. Int. J. Rod. Oncol. Biol. Phys. 1983; 9: 1029–1023
  • Weiner R. S., Bortin M. M., Gale R. P., et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann. Intern. Med. 1986; 104: 168–175
  • Sutton L., Kuentz M., Cordonnier C., et al. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant‐related mortality and influence of total body irradiation modalities. Bone Marrow Transplant. 1993; 12: 583–589
  • Mehta J., Powles R., Singhal S., Horton C., Tait D., Treleaven J. Melphalan‐total body irradiation and allogeneic bone marrow transplantation for acute myeloid leukemia in first remission. Bone Marrow Transplant. 1996; 17(Suppl 1)S22
  • Mehta J., Powles R., Singhal S., Tait D., Swansbury J., Treleaven J. Cytokine‐mediated immunotherapy with or without donor leukocytes for poor‐risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995; 16: 133–137
  • Mehta J., Powles R., Singhal S., et al. Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors. Bone Marrow Transplant. 1995; 16: 499–506

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.